ADA Scientific Sessions 2026 Abstract·5 JunIGlarLixi Improves PPG and DTIR in Asian People with T2D (PwT2D): Post Hoc Pooled Analysis of Ph3 StudiesTrial in peopleInterventionsPaper
ADA Scientific Sessions 2026 Abstract·5 JunImpact of IGlarLixi on Glycemic Variability (GV): A Participant-Level Exploratory Pooled Analysis of the Global LixiLan Clinical Trial ProgramTrial in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunGlycemic Outcomes When Switching to iGlarLixi from Premixed Insulin (PI) in People with Type 2 Diabetes (T2D) by iGlarLixi Pen Subgroups—Post Hoc Analysis of Soli-SWITCHTrial in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunEarly Glycemic Improvement When Switching to iGlarLixi from Premixed Insulins (PI) in Adults with Type 2 Diabetes (T2D)—A Post Hoc Analysis of Soli-SWITCHTrial in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunImpact of Time of Injection Comparing iGlarLixi vs. IDegAsp in Chinese People with Type 2 Diabetes—Exploratory Analysis of the SoliD StudyTrial in peopleInterventionsPaper